Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation

@inproceedings{Soubra2012LubiprostoneFT,
  title={Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation},
  author={Mahmoud Soubra and Ron Schey},
  booktitle={Clinical medicine insights. Gastroenterology},
  year={2012}
}
Irritable bowel syndrome with constipation (IBS-C) affects approximately 5% of the population in western countries. The majority of those afflicted are women. Symptoms are often detrimental to the individual's quality of life and incur high healthcare costs to society. There is no evidence to support changes in lifestyle, laxatives or over the counter supplements. Tegaserod appeared to have promising results but was promptly removed from the market due to adverse cardiovascular events. In 2008… CONTINUE READING